Efavirenz to Nevirapine Switch in HIV-1 Infected Patients With Severe Dyslipidemia: A Randomized Controlled Study.
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2010
At a glance
- Drugs Efavirenz; Nevirapine
- Indications HIV-1 infections
- Focus Adverse reactions
- Acronyms SIROCCO
- 16 Oct 2008 Status changed from discontinued to completed, as reported by ClinicalTrials.gov.
- 26 Jan 2007 New trial record.